Quantum Financial Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-551
Closed -$214K 206
2025
Q2
$214K Hold
551
0.03% 170
2025
Q1
$240K Sell
551
-1
-0.2% -$401 0.04% 146
2024
Q4
$204K Hold
552
0.03% 181
2024
Q3
$287K Sell
552
-25
-4% -$13.4K 0.04% 131
2024
Q2
$313K Hold
577
0.05% 114
2024
Q1
$299K Sell
577
-2
-0.3% -$995 0.06% 117
2023
Q4
$273K Hold
579
0.07% 87
2023
Q3
$252K Hold
579
0.07% 90
2023
Q2
$257K Hold
579
0.08% 74
2023
Q1
$266K Hold
579
0.08% 70
2022
Q4
$297K Buy
579
+1
+0.2% +$508 0.13% 58
2022
Q3
$262K Hold
578
0.12% 55
2022
Q2
$278K Buy
+578
New +$286K 0.1% 65

Other funds holding ELV

Quantum Financial Advisors's ELV Position: Q3 2025 in Review

Quantum Financial Advisors sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 551 shares — an estimated $214K sold.

Quantum Financial Advisors first reported a position in ELV in Q2 2022 and held it in 13 quarters. The position peaked at $313K in Q2 2024. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Quantum Financial Advisors reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Quantum Financial Advisors sold 551 Elevance Health shares in Q3 2025, an estimated $214K.
  • Quantum Financial Advisors first reported a position in Elevance Health in Q2 2022 and held it in 13 quarters.
  • Quantum Financial Advisors's Elevance Health position peaked at $313K in Q2 2024.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Quantum Financial Advisors's 13F filing for Q3 2025, filed 8 Oct 2025.